Eris Lifesciences Ltd
BSE: 540596
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 443.99+60.1% | 277.31-12.0% | 315.29-51.5% | 650.50+12.4% | 578.64+43.0% | 404.77+1.3% | 399.73-6.8% | 428.75 |
| Other Income | 26.38-2.2% | 26.97+7.6% | 25.07+6.3% | 23.59+4.0% | 22.68+35.4% | 16.75+115.0% | 7.79-42.8% | 13.62 |
| Total Income | 470.37+54.6% | 304.28-10.6% | 340.36-49.5% | 674.09+12.1% | 601.32+42.7% | 421.52+3.4% | 407.52-7.9% | 442.37 |
| EXPENSES | ||||||||
| Expenditure | 406.23+20.5% | 337.05+4.7% | 321.80-26.8% | 439.42-1.3% | 445.06+17.0% | 380.34-5.3% | 401.49+1.3% | 396.35 |
| Tax | 15.84+165.5% | -24.17-3121.3% | 0.80-99.1% | 85.10+51.2% | 56.27+425.4% | 10.71+152.0% | 4.25-76.3% | 17.92 |
| PROFIT | ||||||||
| PBT | 64.14+295.7% | -32.77-942.4% | 3.89-98.3% | 234.67+50.2% | 156.26+279.5% | 41.18+582.9% | 6.03-86.9% | 46.02 |
| Net Profit | 48.30+661.6% | -8.60-378.3% | 3.09-97.9% | 149.57+49.6% | 99.99+228.2% | 30.47+1611.8% | 1.78-93.7% | 28.10 |
| KEY METRICS | ||||||||
| OPM % | 27.01%+19.16pp | 7.85%-12.03pp | 19.88%-25.76pp | 45.64%+8.26pp | 37.38%+7.49pp | 29.89%+55.68pp | -25.79%-9.46pp | -16.33% |
| NPM % | 10.27%+13.10pp | -2.83%-3.74pp | 0.91%-21.28pp | 22.19%+5.56pp | 16.63%+9.40pp | 7.23%+6.79pp | 0.44%-5.91pp | 6.35% |
| EPS | 3.49+454.0% | 0.63+173.9% | 0.23-97.9% | 10.98+49.6% | 7.34+227.7% | 2.24+1623.1% | 0.13-93.7% | 2.06 |
Corporate Events
Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗Board Meeting
The Twentieth Annual General Meeting (AGM) of the Members of…
BSE Filing ↗Board Meeting
The Board of Directors approved the re-appointment of Mr. S…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
The board meeting is scheduled to consider and approve the s…
BSE Filing ↗Board Meeting
Consider and approve the standalone and consolidated
BSE Filing ↗Board Meeting
consider and approve the standalone and consolidated audited…
BSE Filing ↗Board Meeting
Consider and approve standalone and consolidated unaudited f…
BSE Filing ↗Board Meeting
Consideration and approval of the standalone and consolidate…
BSE Filing ↗Board Meeting
consider and approve the standalone and consolidated audited…
BSE Filing ↗Board Meeting
Consider and approve the standalone and consolidated unaudit…
BSE Filing ↗Board Meeting
Consider and approve the standalone and consolidated unaudit…
BSE Filing ↗Board Meeting
consider and approve the standalone and consolidated unaudit…
BSE Filing ↗